logo

For the Inventor, By the Inventor

Seoul, South Korea

Medipost Co., Ltd


USPTO Granted Patents = 15



Trademarks = 2

Forward Citations = 37

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Yoon-Sun Yang (13 out of 14 patents)

silverMedal Won Il Oh (8 out of 8 patents)

bronzeMedal Hong Bae Jeon (6 out of 7 patents)

4.  Jong Wook Chang (5 out of 10 patents)

5.  Wonil Oh (4 out of 4 patents)

6.  Sun Jae Kwon (3 out of 3 patents)

7.  Soo Jin Choi (3 out of 8 patents)

8.  Mi Yeon Lee (3 out of 4 patents)

9.  Miyeon Kim (2 out of 3 patents)

10.  Ju-Yeon Kim (2 out of 2 patents)

11.  Mee Hyun Jung (2 out of 2 patents)

12.  Sang Young Jeong (2 out of 2 patents)

13.  Hye Jin Jin (2 out of 2 patents)

14.  Yun Sil Chang (1 out of 12 patents)

15.  Yoon Sun Yang (1 out of 1 patent)


15 patents:

1. 12303534 - Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory disease (2025-05-20),
2. 11332715 - Method for culturing mesenchymal stem cells (2022-05-17),
3. 10307442 - Pharmaceutical composition for the prevention or treatment of a pulmonary disorder comprising mesenchymal stem cells having improved proliferation and differentiation capacity (2019-06-04),
4. 10294456 - Method for culturing mesenchymal stem cells (2019-05-21),
5. 10238692 - Composition comprising a culture solution of mesenchymal stem cells for the treatment of neural diseases (2019-03-26),
6. 10150950 - Method for culturing mesenchymal stem cells according to cell size (2018-12-11),
7. 9580687 - Method for culturing mesenchymal stem cells (2017-02-28),
8. 9498497 - Method of treating lung diseases using cells separated or proliferated from umbilical cord blood (2016-11-22),
9. 9439931 - Administering umbilical cord blood-derived mesenchymal stem cells to treat nerve injury (2016-09-13),
10. 9408892 - Treating cartilage defect with UCB-MSC expressing TSP-2 (2016-08-09),
11. 9387226 - Neural cell proliferation induced through the culture of neural cells with umbilical cord blood-derived mesenchymal stem cells (2016-07-12),
12. 9040298 - Method of selecting stem cells having high chondrogenic differentiation capability (2015-05-26),
13. 8614191 - Use of ICAM-1 for prevention or treatment of neurological diseases (2013-12-24),
14. 8506948 - UCB-MSCs comprising a tumor suppressor gene reduce the size of an IL-8 or GRO-αexpressing tumor (2013-08-13),
15. 7459307 - Composition for treatment of articular cartilage damage (2008-12-02),
MEDIPOST CO., LTD is a biotechnology company based in South Korea. We specialize in stem cell research, development, and therapeutics. Utilizing advanced technology and innovative approaches, we aim to improve the quality of life for patients suffering from various diseases. Our team of experts is dedicated to discovering novel therapies and delivering them to the market. Visit our website for more information about our cutting-edge solutions and ongoing research projects.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#236 in Seoul

#738 in South Korea

#38,719 in the World

...
Seoul, South Korea

Medipost Co., Ltd

Forward Citations = 37

27 inventors:

goldMedal Yoon-Sun Yang (13 out of 14 patents)

silverMedal Won Il Oh (8 out of 8 patents)

bronzeMedal Hong Bae Jeon (6 out of 7 patents)

4.  Jong Wook Chang (5 out of 10 patents)

5.  Wonil Oh (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…